Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEDate | Cost of Revenue |
---|---|
6/30/2025 | $ 396M |
3/31/2025 | $ 625.2M |
12/31/2024 | $ 681.3M |
9/30/2024 | $ 748.4M |
6/30/2024 | $ 802.6M |
3/31/2024 | $ 697.1M |
12/31/2023 | $ 705.4M |
9/30/2023 | $ 743M |
6/30/2023 | $ 713.7M |
3/31/2023 | $ 692.9M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Minimum
Jun 30, 2025
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 2.95K |
---|---|
min | $ -168.96M |
max | $ 758.54M |
average | $ 111.83M |
median | $ 13.43M |
std | $ 181.64M |